Literature DB >> 8676511

A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro.

A Fernandez-Sesma1, J L Schulman, T M Moran.   

Abstract

Bispecific antibodies can be used to redirect cytotoxic T cells to kill virus-infected cells, overriding the need for major histocompatibility complex restriction. We produced a bispecific antibody (3F12) which binds influenza virus M2 protein and the T-cell receptor and can redirect staphylococcal enterotoxin B-activated T cells to kill influenza virus-infected cells and inhibit virus replication in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676511      PMCID: PMC190421     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Hybrid hybridomas and their use in immunohistochemistry.

Authors:  C Milstein; A C Cuello
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

3.  Bispecific antibodies and targeted cellular cytotoxicity.

Authors:  M W Fanger; D M Segal; J L Romet-Lemonne
Journal:  Immunol Today       Date:  1991-02

4.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.

Authors:  J A Titus; M A Garrido; T T Hecht; D F Winkler; J R Wunderlich; D M Segal
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

6.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 7.  Principles for adoptive T cell therapy of human viral diseases.

Authors:  S R Riddell; P D Greenberg
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

9.  Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody.

Authors:  P Perez; R W Hoffman; S Shaw; J A Bluestone; D M Segal
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

10.  Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.

Authors:  G J Weiner; J R Hillstrom
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

View more
  5 in total

1.  Influenza virus evades innate and adaptive immunity via the NS1 protein.

Authors:  Ana Fernandez-Sesma; Svetlana Marukian; Barbara J Ebersole; Dorothy Kaminski; Man-Seong Park; Tony Yuen; Stuart C Sealfon; Adolfo García-Sastre; Thomas M Moran
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.

Authors:  Angela Granelli-Piperno; Alla Pritsker; Maggi Pack; Irina Shimeliovich; Jean-Francois Arrighi; Chae Gyu Park; Christine Trumpfheller; Vincent Piguet; Thomas M Moran; Ralph M Steinman
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.

Authors:  Sweety Samal; Tripti Shrivastava; Praveen Sonkusre; Zaigham Abbas Rizvi; Rajesh Kumar; Shubbir Ahmed; Preeti Vishwakarma; Naveen Yadav; Manish Bansal; Kanchana Chauhan; Sebanta Pokhrel; Supratik Das; Padmakar Tambare; Amit Awasthi
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

Review 4.  M2e-based universal influenza vaccines: a historical overview and new approaches to development.

Authors:  Daria Mezhenskaya; Irina Isakova-Sivak; Larisa Rudenko
Journal:  J Biomed Sci       Date:  2019-10-19       Impact factor: 8.410

5.  N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

Authors:  Wanli Liu; Hua Li; Ying-Hua Chen
Journal:  FEMS Immunol Med Microbiol       Date:  2003-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.